Date: August 31st, Thursday 23:00-24:00 Sponsorship: UBS Securities For institutional investors Topic: Cancer Enterprise Progress from June 2017, Highlights of DS-8201 Data from ASCO 2017 Speaker: Antoine Yver MD, MSc, EVP, Global Head of Oncology R&D and Chair of Cancer Enterprise
